Fentanyl and fentanyl analogs in the illicit stimulant supply: results from U.S. drug seizure data, 2011-2016.
Open accessAbstract
Background. U.S. research examining the illicit drug supply remain rare even though the information could help reduce overdoses. Relatively little is known regarding how often opioids are found in stimulants and whether temporal and geographic trends exist. We examined trends in fentanyl-cocaine and fentanyl-methampheatmine combinations in the national illicit drug supply. Methods. We analysed serial cross-sectional data from the National Forensic Laboratory Information System (NFLIS) collected between January 2011 and December 2016. We restricted the analysis to cocaine (N=1,389,968) and methamphetamine (n=1,407,474) samples and calculated proportions containing fentanyl (including 23 related analogs) over time. Results. The combined presence of fentanyl and cocaine steadily increased nationally between 2012-2016 (p=0.01), and the number of such samples tripled from 2015-2016 (n=423 to n=1,325). Similarly, the combined presence of fentanyl and methamphetamine increased 179% from 2015-2016 (n=82 to n=272). Patterns varied widely by state; in2016, fentanyl-cocaine samples were most common in New Hampshire (7.2%), Connecticut (5.4%), Ohio (2.6%) and Massachusetts (2.1%), whereas fentanyl-methamphetamine samples were most often in New Hampshire (6.1%), Massachusetts (5.6%), Vermont (2.4%) and Maine (1.2%). Conclusions. Although relatively uncommon, the presence of fentanyl in the stimulant supply increased significantly between 2011 and 2016, with the greatest increases occuring between 2015 to 2016; the presence of these products were concentrated in the U.S. Northeast. Given these trends, strengthening community-based drug checking programs and surveillance within the public health infrastructure could help promote timely responses to novel threats posed by rapid shifts in the drug supply that may lead to inadvertent exposures.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Absolute counts of nitazene reports are correlated with overdose rates and are widely used proxies for street-level drug availability.
“Absolute counts have been used in prior studies, are correlated with overdose rates and are widely used proxies for street‐level drug availability [21, 22, 23, 24].”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [21]
The Methods and Results (pages unavailable) show that the paper used seizure-sample counts and found a state-level correlation between the proportion of stimulant samples containing fentanyl or its analogs and opioid overdose mortality rates. It does not establish a correlation for absolute counts of nitazene reports, or say that such counts are widely used proxies for street-level availability. The Discussion also cautions that seizure data may give a biased picture of the drug supply. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The new Jim Crow: mass incarceration in the age of colorblindness
(2010) · Choice Reviews Online · doi:10.5860/choice.48-1766 · Cited by 4,414 · see citing works
The New Jim Crow: Mass Incarceration in the Age of Colorblindness
Hauhart, R. C. (2011) · Contemporary Sociology A Journal of Reviews · doi:10.1177/0094306111419111 · Cited by 2,743 · see citing works
Drug Overdose Deaths in the United States, 1999–2020
Hedegaard, H., Miniño, A., Spencer, M. R., & Warner, M. (2021) · doi:10.15620/cdc:112340 · Cited by 1,283 · see citing works
(2022) · doi:10.15620/cdc:122556 · Cited by 562 · see citing works
Connor, J. P., Gullo, M. J., White, A., & Kelly, A. B. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000069 · Cited by 462 · see citing works
Fentanyl in the US heroin supply: A rapidly changing risk environment
Ciccarone, D. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.010 · Cited by 451 · see citing works
Gladden, R. M., Martínez, P. D., & Seth, P. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533a2 · Cited by 426 · see citing works
Kariisa, M., Scholl, L., Wilson, N. O., Seth, P., & Hoots, B. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6817a3 · Cited by 401 · see citing works
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19
Alexander, G. C., Stoller, K. B., Haffajee, R. L., & Saloner, B. K. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1141 · Cited by 378 · see citing works
Self-citationTwin epidemics: The surging rise of methamphetamine use in chronic opioid users
Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.029 · Cited by 356 · see citing works
Harper, L., Powell, J., & Pijl, E. M. (2017) · Harm Reduction Journal · doi:10.1186/s12954-017-0179-5 · Cited by 339 · see citing works
Coffin, P. O., Galea, S., Ahern, J., Leon, A. C., Vlahov, D., & Tardiff, K. J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00376.x · Cited by 334 · see citing works
Martins, S. S., Sampson, L., Cerdá, M., & Galea, S. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302843 · Cited by 333 · see citing works
Gladden, R. M., O’Donnell, J. K., Mattson, C. L., & Seth, P. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6834a2 · Cited by 285 · see citing works
Tupper, K. W., McCrae, K., Garber, I., Lysyshyn, M., & Wood, E. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.06.020 · Cited by 238 · see citing works
Carroll, J. J., Marshall, B. D. L., Rich, J. D., & Green, T. C. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.023 · Cited by 230 · see citing works
Green, T. C., Park, J. N., Gilbert, M., McKenzie, M., Struth, E., Lucas, R., Clarke, W., & Sherman, S. G. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102661 · Cited by 211 · see citing works
Self-citationWar on Drugs Policing and Police Brutality
Cooper, H. L. F. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2015.1007669 · Cited by 207 · see citing works
Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern
Al-Tayyib, A., Koester, S., Langegger, S., & Raville, L. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2016.1271432 · Cited by 203 · see citing works
Seal, K. H., Kral, A. H., Gee, L., Moore, L. D., Bluthenthal, R. N., Lorvick, J., & Edlin, B. R. (2001) · American Journal of Public Health · doi:10.2105/ajph.91.11.1842 · Cited by 190 · see citing works
The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms
Jones, C. M., Bekheet, F. N., Park, J. N., & Alexander, G. C. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa011 · Cited by 190 · see citing works
Self-citationPark, J. N., Rouhani, S., Beletsky, L. A., VINCENT, L., Saloner, B. K., & Sherman, S. G. (2020) · Milbank Quarterly · doi:10.1111/1468-0009.12470 · Cited by 165 · see citing works
Self-citationFentanyl shock: The changing geography of overdose in the United States
Zoorob, M. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.04.010 · Cited by 160 · see citing works
Self-citationHoots, B., Vivolo-Kantor, A. M., & Seth, P. (2020) · Addiction · doi:10.1111/add.14878 · Cited by 150 · see citing works
Sherman, S. G., Morales, K. B., Park, J. N., McKenzie, M., Marshall, B. D. L., & Green, T. C. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.03.003 · Cited by 141 · see citing works
Self-citationAmlani, A., McKee, G., Khamis, N., Raghukumar, G., Tsang, E., & Buxton, J. A. (2015) · Harm Reduction Journal · doi:10.1186/s12954-015-0088-4 · Cited by 134 · see citing works
Strickland, J. C., Havens, J. R., & Stoops, W. W. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107592 · Cited by 133 · see citing works
Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD
Mars, S. G., Ondocsin, J., & Ciccarone, D. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1394508 · Cited by 127 · see citing works
Counterfeit Medications and Fentanyl
Green, T. C., & Gilbert, M. K. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.4310 · Cited by 125 · see citing works
An overdose surge will compound the COVID-19 pandemic if urgent action is not taken
Wakeman, S. E., Green, T. C., & Rich, J. D. (2020) · Nature Medicine · doi:10.1038/s41591-020-0898-0 · Cited by 121 · see citing works
Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD
Park, J. N., Weir, B. W., Allen, S. T., Chaulk, P., & Sherman, S. G. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0240-z · Cited by 106 · see citing works
Self-citationToots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
Mars, S. G., Ondocsin, J., & Ciccarone, D. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0232-z · Cited by 96 · see citing works
Rouhani, S., Park, J. N., Morales, K. B., Green, T. C., & Sherman, S. G. (2019) · Harm Reduction Journal · doi:10.1186/s12954-019-0311-9 · Cited by 91 · see citing works
Self-citationO’Donnell, J. K., Gladden, R. M., Mattson, C. L., & Kariisa, M. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6727a4 · Cited by 88 · see citing works
Urban-rural Differences in Drug Overdose Death Rates, by Sex, Age, and Type of Drugs Involved, 2017.
Hedegaard, H. B., Miniño, A., & Warner, M. (2019) · PubMed · Cited by 78 · see citing works
Darke, S. G., Williamson, A. B., Ross, J. E., & Teesson, M. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500286005 · Cited by 74 · see citing works
Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study
Glick, J. L., Christensen, T., Park, J. N., McKenzie, M., Green, T. C., & Sherman, S. G. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.10.017 · Cited by 72 · see citing works
Self-citationExpected and actual fentanyl exposure among persons seeking opioid withdrawal management
Kenney, S. R., Anderson, B. J., Conti, M. T., Bailey, G. L., & Stein, M. D. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.01.005 · Cited by 67 · see citing works
Drug checking to detect fentanyl and new psychoactive substances
Palamar, J. J., Salomone, A., & Barratt, M. J. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000607 · Cited by 55 · see citing works
Schneider, K. E., O’Rourke, A., White, R. H., Park, J. N., Musci, R. J., Kilkenny, M. E., Sherman, S. G., & Allen, S. T. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.102642 · Cited by 54 · see citing works
Self-citationNational Drug Threat Assessment 2006
(2006) · PsycEXTRA Dataset · doi:10.1037/e568962006-001 · Cited by 39 · see citing works
Armenian, P., Whitman, J. D., Badea, A., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6831a2 · Cited by 29 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Barratt MJ, Kowalski M, Maier LJ, Ritter A, 2018 Global review of drug checking services operating in 2017, Drug Policy Modelling Program Bulletin. National Drug and Alcohol Research Center, UNSW, Sydney, Australia.
- Park JN, Rouhani S, Beletsky L, Vincent L, Saloner B, Sherman SG, 2020b Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework. Milbank Q 98(3), 700– 746. 32808709 PMC7482387
Cited by
Sorted by citations
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults
Han, B., Compton, W. M., Jones, C. M., Einstein, E. B., & Volkow, N. D. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.2588 · Cited by 380 · see citing works
Jones, C. M., Houry, D., Han, B., Baldwin, G., Vivolo‐Kantor, A., & Compton, W. M. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14688 · Cited by 202 · see citing works
The opioid overdose crisis as a global health challenge
Krausz, R. M., Westenberg, J. N., & Ziafat, K. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000712 · Cited by 91 · see citing works
Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon
Zoorob, M. J., Park, J. N., Kral, A. H., Lambdin, B. H., & del Pozo, B. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.31612 · Cited by 52 · see citing works
Self-citationPitts, W. J., Heller, D., Smiley‐McDonald, H., Weimer, B., Grabenauer, M., Bollinger, K., Ropero‐Miller, J., & Pressley, D. (2023) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15269 · Cited by 26 · see citing works
Zhu, D. T., Fitzgerald, N. D., Palamar, J. J., & Krotulski, A. J. (2026) · Addiction · doi:10.1111/add.70378 · Cited by 8 · see citing works
“Absolute counts have been used in prior studies, are correlated with overdose rates and are widely used proxies for street-level drug availability [ 21 – 24].”
- Authors
- Park, J. N., Rashidi, E., Foti, K., Zoorob, M., Sherman, S., & Alexander, G. C.
- Affiliations
- Johns Hopkins University (US)
- Harvard University (US)
- Corresponding author
- Park, Ju Nyeong
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 218
- Pages
- 108416
- ISSN
- 0376-8716 (ISSN-L)
- PMC
- PMC7751390
- OpenAlex
- W3106839464
- Semantic Scholar
- 9c60a91c24ac33d2437826abfa4e1f7fb335d5c2
- Cited by
- 128
- References
- 42
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 33 · 2022: 24 · 2021: 14 · 2020: 1
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- fentanyl, fentanyl analogs, illicit drug supply, cocaine, methamphetamine, drug seizures, temporal trends, regional variation, northeastern United States, pharmacovigilance, opioid overdose
- MeSH terms
- Central Nervous System Stimulants, Analgesics, Opioid, Cocaine, Connecticut, Cross-Sectional Studies, Female, Fentanyl, Humans, Maine, Massachusetts, Methamphetamine, New Hampshire, Ohio, Public Health, Illicit Drugs, United States, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review